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Characterization of Renal Cell Carcinoma
Using Agent Detection Imaging:
Comparison with Gray-Scale US
Objective: We wanted to compare the imaging features of renal cell carcinoma
(RCC) and their diagnostic accuracy on agent detection imaging (ADI) and gray-
scale ultrasonography (US). 
Materials and Methods: Thirty non-consecutive patients (age range; 32-80
years, mean age; 53.7 years) with 30 RCCs were examined with gray-scale US
and with ADI in conjunction with using SH U 508A. We described the imaging
features of the renal tumors obtained from ADI according to their enhancement
pattern, the intratumoral anechoic areas and the presence of any pseudocapsule.
The imaging features and diagnostic accuracy of ADI and gray-scale US were
then compared.
Results: On the ADI exam, the RCCs were shown as being heterogeneous in
87% of the cases (26/30), homogeneous in 7% of the cases (2/30), and there
was peripheral irregular enhancement in 7% of the cases (2/30). Intratumoral
anechoic areas and pseudocapsule were seen in 87% and 77% of the RCCs on
the ADI exam, whereas these features were seen in 53% and 17% of the cases
on the gray-scale US, respectively. The diagnostic sensitivity, specificity, and
accuracy for RCC with ADI were 97%, 93%, and 95%, respectively. However,
those for RCC with using gray-scale US were 70%, 86%, and 78%, respectively.
There was a significant difference for the diagnostic accuracy of RCC between
ADI and gray-scale US (p < 0.05). 
Conclusion: Agent detection imaging can help visualize the enhancement pat-
tern of RCC and improve the diagnostic accuracy of this tumor by better display-
ing the intratumoral anechoic areas and the pseudocapsule than does the gray-
scale US.
he development of ultrasonography (US) has increased the physician’s
ability to detect asymptomatic renal masses. The early detection and
characterization of solid renal masses are of great clinical importance for
their accurate diagnosis, treatment planning and prognosis (1). So far, the role for US
has been mainly centered on the differentiation of renal cell carcinoma (RCC) and
angiomyolipoma (AML), which are the most common malignant and benign solid
renal tumors, respectively (2 6). Although US is considered to be a useful imaging
modality for solid renal masses, its capability for detecting or characterizing lesions is
somewhat limited. A low incidence of specific features or the considerable overlap of
vascular signals still exists between RCC and the other solid renal masses.
Several recent studies have reported that contrast-enhanced harmonic US can
provide a better assessment of vascular morphology and enhancing patterns, and this
can improve the detection and characterization of focal liver lesions (7 9). To the best
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Tof our knowledge, a few studies have reported on the
imaging characterization of RCCs with using contrast-
enhanced harmonic US, but the studies did not completely
evaluate the enhancement patterns and the morphologic
features of RCC as compared with those of the gray-scale
US exam and the pathologic exam (10 12). 
Agent detection imaging (ADI) is a contrast-enhanced
harmonic mode that uses a high mechanical index, and this
can provide high spatial resolution and the segmental
display of contrast and tissue images. The purpose of this
study is to compare the imaging features of RCC and their
diagnostic accuracy on ADI and gray-scale US.
MATERIALS AND METHODS
Patients
During a 10-month period, 30 non-consecutive patients
(6 males and 24 females [age range; 32 80 years, mean
age; 53.7 years]) with 30 RCCs that were detected on CT
scan were referred to us for performing US before the
masses were histologically confirmed. All of the patients
underwent a gray-scale US and an ADI scan that were
performed by one radiologist (B.K.P.). All the patients
gave us an informed written consent for the ADI, and this
study was approved by the institutional review board of
the Seoul National University Hospital, Korea. 
The RCCs measured from 1.5 cm to 10 cm in size (mean
standard deviation; 4.9 2.7 cm) and they consisted of
27 clear cell, two papillary and one chromophobe type
masses. Partial (n=1) or total nephrectomies (n=29) were
performed on all the patients. On the pathologic exams,
pseudocapsule and intratumoral cyst or necrosis were
found in 93% (28/30) and 90% (27/30) of all the RCCs.
US Exams
The US contrast agent used in this study was SH U 508A
(Levovist; Schering AG, Berlin, Germany); it consists of
galactose microparticles (99.9%) and palmitic acid (0.1%).
Four grams of SH U 508 A at a concentration of 300
mg/ml were intravenously administered by a manual bolus
injection via an 18-gauge cannula inserted into an antecu-
bital vein.
The US exams were performed with a high-resolution
US unit (Sequoia; Siemens Medical Solutions,
Mountainview, CA, USA) that was equipped with ADI
software. The acoustic power of the ADI was adjusted to
the default maximal setting (mechanical index, 1.9). The
dynamic range was set to 50 55 dB. The line density and
frame rate were lowered to 9 Hz without frame averaging.
A 4C1 convex-array probe only was used for the ADI
scan. Before the ADI scan, the gray-scale exam was
conducted (a) in order to determine the optimal imaging
plane to display the renal masses because the shorter the
distance between the probe and the renal masses, the
stronger the signal, (b) to compare the diagnostic accuracy
between the gray-scale US and the ADI. 
Real-time scanning commenced immediately after the
intravenous injection of the contrast agent, and the scan
time was measured when the contrast agent passed the
intravenous cannula. When the first signal of contrast
agent appeared in the kidney, we rapidly moved the probe
to cover the region including the lesions. Rapid sweeping
was repeated every 10 15 seconds (interval delay scan).
For each sweep, we used clip store that can record the
continuous images displayed on the monitor during a 6-
second period, in a manner similar to video recording, and
we also captured still images by employing cine loops. All
of the scanned images were automatically stored in the
picture archiving communication system (Marotech, Seoul,
Korea). The scan time used for ADI was usually about 5
minutes. 
Imaging Analysis
Two radiologists (S.H.K. and H.J.C) working in consen-
sus retrospectively analyzed all of the US images for the
enhancement patterns and the presence or absence of
intratumoral anechoic areas and pseudocapsule. The
enhancement patterns of the tumor were classified as
homogeneous, heterogeneous, stippled and peripheral
irregular enhancement. Homogeneous enhancement was
defined as an even signal intensity over the whole tumor
with no signal defects. Heterogeneous enhancement was
defined as an uneven signal intensity over the whole
lesion. Stippled enhancement was defined as tiny enhanc-
ing foci distributed throughout the entire lesion. Peripheral
irregular enhancement was defined as a discontinuous ring
of contrast-enhanced peripheral nodules. 
Intratumoral anechoic areas were classified as intratu-
moral cysts and necrosis. Intratumoral cysts or necrosis
were noted depending on whether the contour of the
signal defect was smooth or irregular. 
Pseudocapsule was defined as a hypoechoic halo on the
gray-scale US and as a peritumoral rim that showed no
enhancement in the early phase and delay enhancement in
the late phase of ADI.
Comparison of the Diagnostic Accuracy between Gray-
scale US and ADI
We retrospectively compared the diagnostic accuracy for
RCC between the gray-scale US and the ADI. On the gray-
scale US examination, when the lesion had more than two
imaging features among intratumoral anechoic areas,
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the normal renal parenchyma, then we made a diagnosis of
RCC. On the ADI exam, when the lesion had more than
two imaging features among the most common enhance-
ment patterns of RCC, intratumoral anechoic areas and
pseudocapsule, then we made a diagnosis of RCC. We then
compared the diagnostic accuracy for RCC between the
gray-scale US and the ADI exam.
Statistical Analysis
Fisher’s exact test was used to compare the imaging
features of RCC that were seen on gray-scale US and ADI.
The diagnostic accuracy, which included the sensitivity,
specificity, positive predictive value, negative predictive
value and overall accuracy for RCC on the ADI exam, was
calculated and then compared with those of the gray-scale
US by using the McNemar test. A p value of less than 0.05
was considered statistically significant. 
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Fig. 1. Small renal cell carcinoma in a 64-year-old man.
A. Transverse image on gray-scale US shows an ill-defined isoechoic mass (arrows) containing suspicious anechoic cysts. Any pseudo-
capsule is not seen around the tumor.
B. The transverse image of agent detection imaging that was obtained 17 seconds after the administration of SH U 508A shows a thick
pseudocapsule (arrows) around the tumor.
C. The transverse image of agent detection imaging that was obtained 34 seconds after the administration of SH U 508A shows hetero-
geneous enhancement of the tumor with multiple anechoic cysts, and these are better depicted here than on gray-scale US. The
pseudocapsule as well as the tumor is also enhanced (arrows). A feeding vessel (blank arrow) is clearly seen on the agent detection
imaging exam.
D. The cut surface of the gross specimen shows small cysts, necrosis and hemorrhage within the renal cell carcinoma (arrows). A
feeding vessel (blank arrow) is demonstrated on the pathologic exam, and this correlated very well with the findings on the agent
detection imaging exam.
CDRESULTS
On the ADI exam, the RCCs showed as being heteroge-
neous in 87% of the patients (26/30), homogeneous in 7%
of the patients (2/30), and peripheral irregular enhance-
ment in 7% of the patients (2/30). Heterogeneous
enhancement was the most common enhancement pattern
of the RCCs, and thus, it was included into the diagnostic
criteria for RCC on the ADI exams (Figs. 1, 2). The RCCs
revealed intratumoral anechoic areas in 87% of the cases
(26/30), and intratumoral cysts (n=25), necrosis (n=21) or
both (n=20) were also noted (Figs. 1, 2). On the gray-scale
US, the intratumoral anechoic areas were seen in 53% of
the cases (16/30), of which ten of the RCCs were not able
to be classified into cysts or necrosis. The intratumoral
anechoic areas were more commonly detected on the ADI
exam than on the gray-scale US (p < 0.05). Pseudocapsule
was seen in 77% of the cases (23/30) of RCC on the ADI
exam, whereas it was seen only in 17% of the cases (5/30)
of RCC on the gray-scale US (p < 0.05) (Figs. 1, 2). RCCs
appeared as hyperechoic in 90% of the cases (27/30), and
as iso or hypoechoic in 10% of the cases (3/30), relative to
the normal renal parenchyma (Figs. 1, 2).
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Fig. 2. Renal cell carcinoma in a 60-year-old man.
A. Transverse image of the gray-scale US shows a slightly hyperechoic solid mass (arrows) with no intratumoral anechoic areas and a
pseudocapsule in the right kidney.
B. Transverse image of agent detection imaging that was obtained 15 seconds after the administration of SH U 508A shows heteroge-
neous enhancement of the tumor with a thin pseudocapsule (arrows).
C. Transverse image of agent detection imaging that was obtained 1 minute after the administration of SH U 508A shows heterogeneous
enhancement of the tumor with multiple intratumoral anechoic areas (blank arrows). The pseudocapsule is not clearly seen due to the
delayed enhancement. 
D. The cut surface of the gross specimen shows multiple small cystic and necrotic portions (blank arrows) in the renal cell carcinoma with
a pseudocapsule (arrows).
CDTable summarizes the diagnostic accuracy of RCC with
using ADI and gray-scale US. When the presence of two or
more ADI features was noted out of heterogeneous
enhancement, intratumoral anechoic areas and pseudocap-
sule, then this was regarded as positive findings for RCC,
and the sensitivity, specificity, and accuracy for RCC were
97%, 93%, and 95%, respectively. However, those for the
RCC on the gray-scale US were 70%, 86%, and 78%,
respectively and its diagnostic accuracy were significantly
different from that of the ADI (p < 0.05). 
DISCUSSION
Agent detection imaging is a microbubble-specific
harmonic US modality that is designed for the optimal
detection of signals from SH U 508A with using high
mechanical index technique (8, 9). It can produce signals
from stationary microbubbles as easily as from those that
are moving in the vessels, and this unlike conventional US
that relies on Doppler shift signals. Other techniques of the
gray-scale contrast-enhanced harmonic imagings such as
pulse inversion harmonic imaging (PIHI) and coded
harmonic imaging (CHA), have been developed by various
US equipment manufacturers (7, 10, 11). Pulse inversion
harmonic imaging uses a pair of pulses with opposite
polarity, and the nonlinear echoes of the tissue harmonic
and the contrast agent responses are detected, while the
linear echoes of the fundamental tissue are canceled.
Coded harmonic imaging uses digital encoding and
decoding of the transmitted pulses, and it can separate the
contrast from the tissue and reduce the unwanted echoes
from the fundamental frequency and the tissue harmonic
signals. Agent detection imaging uses two pulses with the
same polarity and it subtracts the signals from the two
pulses. 
The introduction of US has led to improving the
detection of renal tumors in asymptomatic patients. Renal
cell carcinoma seen on gray-scale US has specific features
including intratumoral cyst and pseudocapsule, and AML
characteristically shows posterior shadowing (2 4). These
features are important findings that may help distinguish
RCC from AML, but the presence of these features is not
sufficient to differentiate RCCs from the other solid renal
masses that are incidentally detected on gray-scale US. On
the power Doppler US, the analysis of the vascular distrib-
ution has not increased the diagnostic accuracy for small
solid renal tumors (4). Contrast-enhanced Doppler US can
increase the detection of intratumoral vascularity
compared to color/power Doppler US (5, 6). However, its
signal intensity hasn’t been found to be sufficiently intense
for tumor characterization, and it contains artifacts or
noises that prevent a correct diagnosis. Recently, the
development of contrast-enhanced harmonic US imaging
has provided for a better assessment of the vascular
morphology and the enhancing patterns; thus, it has
improved the detection and characterization of focal liver
lesions (7 9). To the best of our knowledge, there have
been a few reports about the differentiation of RCC with
employing contrast-enhanced harmonic US imaging using
SH U 508A (10 12). However, these studies did not
completely evaluate the various enhancement patterns and
the intratumoral or peritumoral features of RCC on the
ADI exam as compared with those features on the gray-
scale US and pathologic exams. 
On the ADI exam, heterogeneous enhancement was
most commonly seen in the RCC because most of the
lesions contain intratumoral signal defects that pathologi-
cally corresponded to cystic change, necrosis or both.
Homogeneous enhancement was shown for the small
RCCs, and cystic change or necrosis was not found in these
tumors on the pathologic exam. Peripheral irregular
enhancement was seen in those RCCs with a large
necrosis.
Intratumoral anechoic areas have been reported to be
pathologically cystic change, degeneration or necrosis. On
gray-scale US, these were specific for RCC, but their
frequency was previously reported as being 12 31% (2
4). The number of intratumoral cysts in the RCCs was
larger on the AD scan than on the gray-scale US because
the signal of the contrast agent on the ADI can be seen in
almost all the tissue with vessels, except for the avascular
areas such as cysts or necrosis. 
The pseudocapsule pathologically corresponds to fibrous
tissue and renal parenchyma that is compressed by the
RCC (13, 14). The preoperative identification of the
pseudocapsule was one of the criteria that allow nephron-
sparing surgery (15). Ascenti et al., reported that the
pseudocapsule appeared as a nonenhancing peritumoral
rim in the early phase and as a well-enhancing rim in the
late phase on the contrast-enhanced harmonic US (12). In
their study, the contrast-enhanced second-harmonic US
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Table 1. Comparison of the Diagnostic Accuracy for Renal
Cell Carcinoma with Using Agent Detection Imaging
and Gray-Scale US (p < 0.05)
Agent Detection Imaging Gray-Scale US
Sensitivity 97% 70%
Specificity 93% 86%
Positive predictive value 94% 84%
Negative predictive value 96% 74%
Overall accuracy 95% 78%Park et al.
178 Korean J Radiol 6(3), September 2005
showed a higher sensitivity for the peritumoral pseudocap-
sule of RCC than did the gray-scale US (12). Similarly, the
gray-scale US and ADI detected the encapsulated RCCs in
18% (5/28) and 82% (23/28) of all the cases, respectively.
This study has a few limitations. First, only a small
number of patients with RCC were included in the study.
A larger scale of study will be necessary to support our
results for the ADI exam. Second, it was nearly impossible
for us to detect the contrast signals of the RCC situated 10
cm or deeper from the US probe. Body habitus, lung or
bowel gas, ribs and the location of the lesions also affected
the signal intensity of the renal tumors. Third, color/power
Doppler US, which can provide more information on
intratumoral vascular distribution, was not performed to
evaluate the RCC in this study. It is necessary to compare
the diagnostic accuracy between the ADI scan and the
combination of gray-scale US with power Doppler US for
the diagnostic accuracy of the solid renal masses. Fourth,
the diagnostic criteria for RCC with using gray-scale US
and ADI exams have not been established. We made a
diagnosis of RCC when the tumor showed two out of the
three most common imaging features on the gray-scale US
and ADI exams.
In conclusion, ADI can describe the enhancement
patterns of RCC. It can improve the diagnostic accuracy of
RCC as compared with gray-scale US by allowing better
visualization of the intratumoral anechoic areas and the
pseudocapsule than can the gray-scale US.
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